New and developing therapies for atopic dermatitis

被引:43
作者
Hajar, Tamar [1 ]
Gontijo, Joao Renato Vianna [1 ]
Hanifin, Jon M. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
关键词
Dermatitis; atopic; Eczema; Phosphodiesterase inhibitors; Therapeutics; CYCLIC-AMP-PHOSPHODIESTERASE; SKIN BARRIER; IN-VITRO; DUPILUMAB; MODERATE; ADULTS; DERMATOSES; EXPRESSION; APREMILAST; INHIBITOR;
D O I
10.1590/abd1806-4841.20187682
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 26 条
[1]   Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses [J].
Abrouk, Michael ;
Farahnik, Benjamin ;
Zhu, Tian Hao ;
Nakamura, Mio ;
Singh, Rasnik ;
Lee, Kristina ;
Lucking, Sara-Marian ;
Blossom, Jessin ;
Liao, Wilson ;
Koo, John ;
Bhutani, Tina ;
Shinkai, Kanade ;
Nguyen, Tien .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) :177-180
[2]   Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J].
Beck, Lisa A. ;
Thaci, Diamant ;
Hamilton, Jennifer D. ;
Graham, Neil M. ;
Bieber, Thomas ;
Rocklin, Ross ;
Ming, Jeffrey E. ;
Ren, Haobo ;
Kao, Richard ;
Simpson, Eric ;
Ardeleanu, Marius ;
Weinstein, Steven P. ;
Pirozzi, Gianluca ;
Guttman-Yassky, Emma ;
Suarez-Farinas, Mayte ;
Hager, Melissa D. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Radin, Allen R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) :130-139
[3]   Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial [J].
Bissonnette, R. ;
Papp, K. A. ;
Poulin, Y. ;
Gooderham, M. ;
Raman, M. ;
Mallbris, L. ;
Wang, C. ;
Purohit, V. ;
Mamolo, C. ;
Papacharalambous, J. ;
Ports, W. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) :902-911
[4]   Atopic dermatitis: a disease of altered skin barrier and immune dysregulation [J].
Boguniewicz, Mark ;
Leung, Donald Y. M. .
IMMUNOLOGICAL REVIEWS, 2011, 242 :233-246
[5]  
CHAN SC, 1982, J CYCLIC NUCL PROT, V8, P211
[6]   PHOSPHODIESTERASE INHIBITION BY RO 20-1724 REDUCES HYPER-IGE SYNTHESIS BY ATOPIC-DERMATITIS CELLS-INVITRO [J].
COOPER, KD ;
KANG, K ;
CHAN, SC ;
HANIFIN, JM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1985, 84 (06) :477-482
[7]   IL-31 regulates differentiation and filaggrin expression in human organotypic skin models [J].
Cornelissen, Christian ;
Marquardt, Yvonne ;
Czaja, Katharina ;
Wenzel, Joerg ;
Frank, Jorge ;
Luescher-Firzlaff, Juliane ;
Luescher, Bernhard ;
Baron, Jens M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) :426-U235
[8]  
Eichenfield L, 2017, J AM ACAD DERMATOL, V76, pAB423, DOI [DOI 10.1016/J.JAAD.2017.06.133, 10.1016/J. jaad.2017.06.133]
[9]   New insights into the epidemiology of childhood atopic dermatitis [J].
Flohr, C. ;
Mann, J. .
ALLERGY, 2014, 69 (01) :3-16
[10]   ELEVATED LEUKOCYTE CYCLIC-AMP PHOSPHODIESTERASE IN ATOPIC DISEASE - A POSSIBLE MECHANISM FOR CYCLIC-AMP AGONIST HYPORESPONSIVENESS [J].
GREWE, SR ;
CHAN, SC ;
HANIFIN, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (06) :452-457